As you prepare to manufacture your Adeno-Associated Virus (AAV) vectors, you may face some hurdles such as scalability, production yields, and a clean feed-stream to facilitate effective purification strategies.

At Andelyn, we have developed a high yielding, scalable suspension platform that helps you overcome these challenges.

In this webinar, you’ll learn how our platform helps you:

• Scale up your production: Discover how our DOE-based strategy helps ensure a scalable process to help you ramp up your production efforts.
• Achieve efficiency in transfection: Learn more about how our FectoVIR®-AAV transfection reagent combined with a triple transient transfection approach enables us to optimize factors such as cell density, plasmid DNA amount, and more.
• Overcome purification problems: Find out how our cutting-edge ultracentrifugation and all-column chromatography-based purification methods help you optimize AAV purification.

You’ll also hear real-world case studies demonstrating our scalability while learning more about our suspension cell line designed to help you achieve higher AAV yields.

Watch the webinar in full.